Montana’s plan to become an experimental medical hub just pushed forward

Montana has created a fast-track approval system allowing biotech companies to sell experimental drugs directly to consumers after minimal testing, sometimes with data from just 10 people. This could put patients at serious risk and represents a significant shift in drug safety oversight that affects public health.